CyclosporineImmunosuppressive AgentsTacrolimusKidney TransplantationGraft RejectionMycophenolic AcidOrgan TransplantationCalcineurinGraft SurvivalTissue and Organ ProcurementCyclophilin AAzathioprineKidneyHeart TransplantationImmunosuppressionLiver TransplantationTransplantation, HomologousDrug Therapy, CombinationSirolimusMultiple Organ FailureOrgan SizeTissue DonorsTime FactorsGraft vs Host DiseaseDrug MonitoringOrgan SpecificityPrednisoneTreatment OutcomeOrgan of CortiAntilymphocyte SerumAnemia, AplasticPrednisoloneNephrotic SyndromeKidney DiseasesBone Marrow TransplantationGingival OvergrowthMethylprednisoloneCyclophilinsTransplantationEmulsionsDermatologic AgentsCreatinineDrug InteractionsTransplantation ImmunologyDose-Response Relationship, DrugAdrenal Cortex HormonesRats, Inbred LewRecurrenceRetrospective StudiesLiverP-GlycoproteinHistocompatibility TestingRats, WistarRats, Inbred WFUveitisArea Under CurveMethotrexateVomeronasal OrganChromatography, High Pressure LiquidSteroidsLung TransplantationKidney Function TestsNephrosis, LipoidRadioimmunoassayGlomerular Filtration RateProspective StudiesSubfornical OrganHistocompatibilityFollow-Up StudiesGlomerulonephritis, MembranousRats, Sprague-DawleyLiving DonorsOphthalmic SolutionsAcute DiseaseCadaverBiological AvailabilityPsoriasisDrug Administration ScheduleTissue DistributionAdministration, OralT-LymphocytesPostoperative ComplicationsDogsPelvic Organ ProlapseNFATC Transcription FactorsDrug SubstitutionScleritisFluorescence Polarization ImmunoassayCapsulesTransplantation Conditioning